HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities

This publication has 27 references indexed in Scilit:

• A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology
  Journal of Immunological Methods, 2001
• Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes
  Journal of Clinical Investigation, 2000
• Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma
  The Journal of Experimental Medicine, 1999
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
  The Journal of Pathology, 1999
• Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
  Journal of Clinical Investigation, 1999
• Dendritic cells and the control of immunity
  Nature, 1998
• Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
  Nature Medicine, 1998
• Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors
  The Journal of Experimental Medicine, 1997
• Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
  Nature Medicine, 1996
• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
  JNCI Journal of the National Cancer Institute, 1995